Department of Medical Genetics Ankara Etlik City Hospital
Clinical genomics

Hereditary Cancer Genomics

Germline cancer-predisposition testing and interpretation.

Germline testing establishes whether an inherited predisposition explains a cancer diagnosis or a family history, and what that means for relatives. Testing is requested and interpreted within a clinical genetics consultation, with counselling before and after analysis.

Documented capability

  • BRCA1/2 germline analysis and broader multigene hereditary-cancer panels
  • Syndrome-focused germline testing where the clinical picture indicates a specific condition
  • Clinical variant interpretation and classification
  • Genetic counselling for probands and at-risk relatives
  • Cascade testing of relatives once a familial variant is established

Germline BRCA1/2 testing asks whether a person carries an inherited variant in every cell. This is a different question, on a different sample type, from tumour BRCA1/2 analysis performed on tumour tissue — see Solid Tumor Genomics.

This page is informational. It does not accept requests, samples, patient data or genomic files, and provides no result lookup.

Hereditary cancer panels in the catalogue

Genetic Panel Search

4 panels. Panel names, gene counts and gene lists are reproduced from the department’s current NGS panel source document. Panel composition may be revised; the version in force at the time of testing applies.

Hereditary Cancer